195 related articles for article (PubMed ID: 23006321)
21. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
[TBL] [Abstract][Full Text] [Related]
22. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
23. Effects of anti-reflux surgery on weakly acidic reflux and belching.
Broeders JA; Bredenoord AJ; Hazebroek EJ; Broeders IA; Gooszen HG; Smout AJ
Gut; 2011 Apr; 60(4):435-41. PubMed ID: 21193452
[TBL] [Abstract][Full Text] [Related]
24. Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study.
Wilder-Smith C; Backlund A; Eckerwall G; Lind T; Fjellman M; Röhss K
Clin Drug Investig; 2008; 28(6):333-43. PubMed ID: 18479175
[TBL] [Abstract][Full Text] [Related]
25. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of esomeprazole for treatment of poorly controlled asthma.
; Mastronarde JG; Anthonisen NR; Castro M; Holbrook JT; Leone FT; Teague WG; Wise RA
N Engl J Med; 2009 Apr; 360(15):1487-99. PubMed ID: 19357404
[TBL] [Abstract][Full Text] [Related]
27. Twelve months' follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study.
Montgomery M; Håkanson B; Ljungqvist O; Ahlman B; Thorell A
Scand J Gastroenterol; 2006 Dec; 41(12):1382-9. PubMed ID: 17101568
[TBL] [Abstract][Full Text] [Related]
28. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.
Tsai HH; Chapman R; Shepherd A; McKeith D; Anderson M; Vearer D; Duggan S; Rosen JP;
Aliment Pharmacol Ther; 2004 Sep; 20(6):657-65. PubMed ID: 15352914
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of laparoscopic fundoplication in patients with chronic cough and gastro-oesophageal reflux.
Frankel A; Ong HS; Smithers BM; Nathanson LK; Gotley DC
Esophagus; 2023 Jan; 20(1):170-177. PubMed ID: 36201134
[TBL] [Abstract][Full Text] [Related]
30. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication.
Broeders JA; Draaisma WA; Bredenoord AJ; de Vries DR; Rijnhart-de Jong HG; Smout AJ; Gooszen HG
Br J Surg; 2009 Sep; 96(9):1023-30. PubMed ID: 19672931
[TBL] [Abstract][Full Text] [Related]
31. Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling.
Timms C; Thomas PS; Yates DH
J Breath Res; 2012 Mar; 6(1):016003. PubMed ID: 22233591
[TBL] [Abstract][Full Text] [Related]
32. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.
Kiljander TO; Harding SM; Field SK; Stein MR; Nelson HS; Ekelund J; Illueca M; Beckman O; Sostek MB
Am J Respir Crit Care Med; 2006 May; 173(10):1091-7. PubMed ID: 16357331
[TBL] [Abstract][Full Text] [Related]
33. Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma.
Carpagnano GE; Resta O; Ventura MT; Amoruso AC; Di Gioia G; Giliberti T; Refolo L; Foschino-Barbaro MP
J Intern Med; 2006 Mar; 259(3):323-31. PubMed ID: 16476110
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and current management of gastrooesophageal-reflux-related asthma.
Menes T; Lelcuk S; Spivak H
Eur J Surg; 2000 Aug; 166(8):596-601. PubMed ID: 11003425
[TBL] [Abstract][Full Text] [Related]
35. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis.
Lundell L; Miettinen P; Myrvold HE; Hatlebakk JG; Wallin L; Malm A; Sutherland I; Walan A;
Br J Surg; 2007 Feb; 94(2):198-203. PubMed ID: 17256807
[TBL] [Abstract][Full Text] [Related]
36. Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.
Ekesbo R; Sjöstedt S; Sörngård H
Clin Drug Investig; 2011; 31(3):181-9. PubMed ID: 21288053
[TBL] [Abstract][Full Text] [Related]
37. Airway hyperresponsiveness and airway inflammation in elite swimmers.
Clin Respir J; 2009 Jan; 3(1):62. PubMed ID: 20298376
[TBL] [Abstract][Full Text] [Related]
38. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
[TBL] [Abstract][Full Text] [Related]
39. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S
Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489
[TBL] [Abstract][Full Text] [Related]
40. Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
Archimandritis AJ; Nikolopoulou V; Kouklakis G; Paraskevas E; Avgerinos A; Tsianos E; Triantafillidis JK;
Curr Med Res Opin; 2005 Apr; 21(4):603-10. PubMed ID: 15899110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
